30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: Medicrea

 (1H14 sales)

€11.9MM (~US $16MM), flat

  • U.S. ~$9MM, +13%
  • France ~$2.6MM, +36%
  • Europe ~$2.8MM, -2%
  • South America ~$1.0MM, -53%
  • Asia ~$0.5MM, -35%


  • Growth in France driven by substantial interest in UNiD customized spinal rods
  • Europe sales stabilizing following 2 years of pricing cuts